These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 16741151)
1. Azithromycin reduces airway neutrophilia and interleukin-8 in patients with bronchiolitis obliterans syndrome. Verleden GM; Vanaudenaerde BM; Dupont LJ; Van Raemdonck DE Am J Respir Crit Care Med; 2006 Sep; 174(5):566-70. PubMed ID: 16741151 [TBL] [Abstract][Full Text] [Related]
2. A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy. Vanaudenaerde BM; Meyts I; Vos R; Geudens N; De Wever W; Verbeken EK; Van Raemdonck DE; Dupont LJ; Verleden GM Eur Respir J; 2008 Oct; 32(4):832-43. PubMed ID: 18827151 [TBL] [Abstract][Full Text] [Related]
3. Long-term azithromycin for bronchiolitis obliterans syndrome after lung transplantation. Gottlieb J; Szangolies J; Koehnlein T; Golpon H; Simon A; Welte T Transplantation; 2008 Jan; 85(1):36-41. PubMed ID: 18192909 [TBL] [Abstract][Full Text] [Related]
4. Montelukast for bronchiolitis obliterans syndrome after lung transplantation: a pilot study. Verleden GM; Verleden SE; Vos R; De Vleeschauwer SI; Dupont LJ; Van Raemdonck DE; Vanaudenaerde BM Transpl Int; 2011 Jul; 24(7):651-6. PubMed ID: 21401732 [TBL] [Abstract][Full Text] [Related]
5. Clinical and immunological evaluation of 12-month azithromycin therapy in chronic lung allograft rejection. Federica M; Nadia S; Monica M; Alessandro C; Tiberio O; Francesco B; Mario V; Maria FA Clin Transplant; 2011; 25(4):E381-9. PubMed ID: 21418327 [TBL] [Abstract][Full Text] [Related]
6. Bronchiolitis obliterans syndrome and restrictive allograft syndrome: do risk factors differ? Verleden SE; Ruttens D; Vandermeulen E; Vaneylen A; Dupont LJ; Van Raemdonck DE; Verleden GM; Vanaudenaerde BM; Vos R Transplantation; 2013 May; 95(9):1167-72. PubMed ID: 23425818 [TBL] [Abstract][Full Text] [Related]
7. A randomised controlled trial of azithromycin to prevent chronic rejection after lung transplantation. Vos R; Vanaudenaerde BM; Verleden SE; De Vleeschauwer SI; Willems-Widyastuti A; Van Raemdonck DE; Schoonis A; Nawrot TS; Dupont LJ; Verleden GM Eur Respir J; 2011 Jan; 37(1):164-72. PubMed ID: 20562124 [TBL] [Abstract][Full Text] [Related]
8. Maintenance azithromycin therapy for bronchiolitis obliterans syndrome: results of a pilot study. Gerhardt SG; McDyer JF; Girgis RE; Conte JV; Yang SC; Orens JB Am J Respir Crit Care Med; 2003 Jul; 168(1):121-5. PubMed ID: 12672648 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of total lymphoid irradiation in azithromycin nonresponsive chronic allograft rejection after lung transplantation. Verleden GM; Lievens Y; Dupont LJ; Van Raemdonck DE; De Vleeschauwer SI; Vos R; Vanaudenaerde BM Transplant Proc; 2009 Jun; 41(5):1816-20. PubMed ID: 19545735 [TBL] [Abstract][Full Text] [Related]
10. Long-term azithromycin use for treatment of bronchiolitis obliterans syndrome in lung transplant recipients. Shitrit D; Bendayan D; Gidon S; Saute M; Bakal I; Kramer MR J Heart Lung Transplant; 2005 Sep; 24(9):1440-3. PubMed ID: 16143268 [TBL] [Abstract][Full Text] [Related]
12. Azithromycin reverses airflow obstruction in established bronchiolitis obliterans syndrome. Yates B; Murphy DM; Forrest IA; Ward C; Rutherford RM; Fisher AJ; Lordan JL; Dark JH; Corris PA Am J Respir Crit Care Med; 2005 Sep; 172(6):772-5. PubMed ID: 15976371 [TBL] [Abstract][Full Text] [Related]
13. Airway neutrophilia in stable and bronchiolitis obliterans syndrome patients following lung transplantation. Zheng L; Walters EH; Ward C; Wang N; Orsida B; Whitford H; Williams TJ; Kotsimbos T; Snell GI Thorax; 2000 Jan; 55(1):53-9. PubMed ID: 10607802 [TBL] [Abstract][Full Text] [Related]
14. Bile acids aspiration reduces survival in lung transplant recipients with BOS despite azithromycin. Mertens V; Blondeau K; Van Oudenhove L; Vanaudenaerde B; Vos R; Farre R; Pauwels A; Verleden G; Van Raemdonck D; Sifrim D; Dupont LJ Am J Transplant; 2011 Feb; 11(2):329-35. PubMed ID: 21272237 [TBL] [Abstract][Full Text] [Related]
15. C-reactive protein in bronchoalveolar lavage fluid is associated with markers of airway inflammation after lung transplantation. Vos R; Vanaudenaerde BM; De Vleeschauwer SI; Willems-Widyastuti A; Dupont LJ; Van Raemdonck DE; Verleden GM Transplant Proc; 2009 Oct; 41(8):3409-13. PubMed ID: 19857759 [TBL] [Abstract][Full Text] [Related]
16. Long-term azithromycin therapy for bronchiolitis obliterans syndrome: divide and conquer? Vos R; Vanaudenaerde BM; Ottevaere A; Verleden SE; De Vleeschauwer SI; Willems-Widyastuti A; Wauters S; Van Raemdonck DE; Nawrot TS; Dupont LJ; Verleden GM J Heart Lung Transplant; 2010 Dec; 29(12):1358-68. PubMed ID: 20619683 [TBL] [Abstract][Full Text] [Related]
17. Azithromycin improves lung function in patients with post-lung transplant bronchiolitis obliterans syndrome: a meta-analysis. Kingah PL; Muma G; Soubani A Clin Transplant; 2014 Aug; 28(8):906-10. PubMed ID: 24931185 [TBL] [Abstract][Full Text] [Related]
18. Comparison of induced sputum and bronchoalveolar lavage in lung transplant recipients. Mamessier E; Milhe F; Badier M; Thomas P; Magnan A; Reynaud-Gaubert M J Heart Lung Transplant; 2006 May; 25(5):523-32. PubMed ID: 16678030 [TBL] [Abstract][Full Text] [Related]
19. Exhaled carbon monoxide as a noninvasive marker of airway neutrophilia after lung transplantation. Vos R; Cordemans C; Vanaudenaerde BM; De Vleeschauwer SI; Schoonis A; Van Raemdonck DE; Dupont LJ; Verleden GM Transplantation; 2009 May; 87(10):1579-83. PubMed ID: 19461497 [TBL] [Abstract][Full Text] [Related]
20. Anti-inflammatory and immunomodulatory properties of azithromycin involved in treatment and prevention of chronic lung allograft rejection. Vos R; Vanaudenaerde BM; Verleden SE; Ruttens D; Vaneylen A; Van Raemdonck DE; Dupont LJ; Verleden GM Transplantation; 2012 Jul; 94(2):101-9. PubMed ID: 22461039 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]